Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2022

25.10.2021 | COVID-19 | Original Article Zur Zeit gratis

Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group

verfasst von: Maral Barzegar-Amini, Mahmoud Mahmoudi, Maliheh Dadgarmoghaddam, Faramarz Farzad, Ali Qaraee Najafabadi, Farahzad Jabbari-Azad

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The present study aimed to compare serum total IgA levels between severe and mild COVID-19 patients’ groups and the control group.

Methods

In this cross-sectional study, 216 definite severe COVID-19 patients (as the inpatient group), 183 subjects with positive specific COVID-19 IgG with mild or no symptoms as the (outpatient group), and 203 healthy subjects with negative specific serology, as the control group were investigated. The cases’ laboratory data were collected, and thereafter, statistical tests, including independent samples t test, ANOVA test, and post hoc test, were performed using SPSS software version 22.

Result

The mean ± SD of IgA in all the included subjects was 2.23 ± 0.78 (g/L). According to the obtained results, there were statistically significant changes in IgA among the three study groups (P value < 0.05). This difference was significant between both outpatient and inpatient groups (P value < 0.05). The mean ± SD of serum IgG in all the subjects was calculated as 15.83 ± 5.73 (g/L). A strong statistically significant change was also seen in IgG among all three groups (P value < 0.001). Of note, there was a significant negative correlation between IgG and IgA total titers of the outpatient group (P value = 0.011*r =  − 0.188).

Conclusion

It was shown that the total serum IgA and IgG levels are significantly associated with the severity of COVID-19 infection. As well, we found that total serum IgA and IgG are associated with the severity of illness. Since a low level of IgA is asymptomatic and high frequent in Iran and other countries, we suggest the evaluation of serum IgA levels in high-risk people and strengthening immune system in subjects with a low level of IgA, in order to reduce the rate of death. In this regard, oral or nasal mucosal vaccines in combination with parenteral vaccination are recommended due to increasing immunity versus COVID-19 by further secretion of the IgA antibody and preventing virus transmission.
Literatur
1.
Zurück zum Zitat Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6.CrossRef Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–6.CrossRef
2.
Zurück zum Zitat Commission WMH. Report of clustering pneumonia of unknown aetiology in Wuhan City. Wuhan Municipal Health Commission. 2019. Commission WMH. Report of clustering pneumonia of unknown aetiology in Wuhan City. Wuhan Municipal Health Commission. 2019.
3.
Zurück zum Zitat Team EE. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Eurosurveillance. 2020;25(5):200131e. Team EE. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Eurosurveillance. 2020;25(5):200131e.
5.
Zurück zum Zitat Richman DD, Whitley RJ, Hayden FG (Eds). Clinical virology: John Wiley & Sons; 2020. Richman DD, Whitley RJ, Hayden FG (Eds). Clinical virology: John Wiley & Sons; 2020.
6.
7.
Zurück zum Zitat de Sousa-Pereira P, Woof JM. IgA: Structure, function, and developability. Antibodies. 2019;8(4):57.CrossRef de Sousa-Pereira P, Woof JM. IgA: Structure, function, and developability. Antibodies. 2019;8(4):57.CrossRef
8.
Zurück zum Zitat Maurer MA, Meyer L, Bianchi M, Turner HL, Le NP, Steck M, et al. Glycosylation of human IgA directly inhibits influenza A and other sialic-acid-binding viruses. Cell Rep. 2018;23(1):90–9.CrossRef Maurer MA, Meyer L, Bianchi M, Turner HL, Le NP, Steck M, et al. Glycosylation of human IgA directly inhibits influenza A and other sialic-acid-binding viruses. Cell Rep. 2018;23(1):90–9.CrossRef
9.
Zurück zum Zitat Wang X, Li Y, Li H, Gu Y, Song Y, Zhang Q, et al. Relationship of serum immunoglobulin levels to blood pressure and hypertension in an adult population. J Hum Hypertens. 2018;32(3):212–8.CrossRef Wang X, Li Y, Li H, Gu Y, Song Y, Zhang Q, et al. Relationship of serum immunoglobulin levels to blood pressure and hypertension in an adult population. J Hum Hypertens. 2018;32(3):212–8.CrossRef
10.
Zurück zum Zitat Hasegawa H, van Reit E, Kida H. Mucosal immunization and adjuvants. Influenza pathogenesis and control-Volume II: Springer; 2014. p. 371-80. Hasegawa H, van Reit E, Kida H. Mucosal immunization and adjuvants. Influenza pathogenesis and control-Volume II: Springer; 2014. p. 371-80.
11.
Zurück zum Zitat Renegar KB, Small PA, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol. 2004;173(3):1978–86.CrossRef Renegar KB, Small PA, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol. 2004;173(3):1978–86.CrossRef
12.
Zurück zum Zitat Watanabe S, Naito Y, Yamamoto T. Host factors that aggravate COVID-19 pneumonia. Int J Fam Med Prim Care. 2020;1(3):1011. Watanabe S, Naito Y, Yamamoto T. Host factors that aggravate COVID-19 pneumonia. Int J Fam Med Prim Care. 2020;1(3):1011.
13.
Zurück zum Zitat World Health Organization. Laboratory testing for coronavirus disease ( COVID-19) in suspected human cases: interim guidance, 19 March 2020. World Health Organization; 2020:1–7. World Health Organization. Laboratory testing for coronavirus disease ( COVID-19) in suspected human cases: interim guidance, 19 March 2020. World Health Organization; 2020:1–7.
14.
Zurück zum Zitat Force ADT, Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, et al. Acute respiratory distress syndrome. JAMA. 2012;307(23):2526–33. Force ADT, Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, et al. Acute respiratory distress syndrome. JAMA. 2012;307(23):2526–33.
15.
Zurück zum Zitat Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.CrossRef Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.CrossRef
16.
Zurück zum Zitat Kardar G, Shams S, Pourpak Z, Moin M. Normal value of immunoglobulins IgA, IgG, and IgM in Iranian healthy adults, measured by nephelometry. J Immunoassay Immunochem. 2003;24(4):359–67.CrossRef Kardar G, Shams S, Pourpak Z, Moin M. Normal value of immunoglobulins IgA, IgG, and IgM in Iranian healthy adults, measured by nephelometry. J Immunoassay Immunochem. 2003;24(4):359–67.CrossRef
17.
Zurück zum Zitat Puissant-Lubrano B, Peres M, Apoil P-A, Congy-Jolivet N, Roubinet F, Blancher A. Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults. Clin Chem Lab Med. 2015;53(12):e359–61.CrossRef Puissant-Lubrano B, Peres M, Apoil P-A, Congy-Jolivet N, Roubinet F, Blancher A. Immunoglobulin IgA, IgD, IgG, IgM and IgG subclass reference values in adults. Clin Chem Lab Med. 2015;53(12):e359–61.CrossRef
18.
Zurück zum Zitat Hasan Ali O, Bomze D, Risch L, Brugger SD, Paprotny M, Weber M, Thiel S, Kern L, Albrich WC, Kohler P, Kahlert CR. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis. 2020; ciab532. https://doi.org/10.1093/cid/ciab532 Hasan Ali O, Bomze D, Risch L, Brugger SD, Paprotny M, Weber M, Thiel S, Kern L, Albrich WC, Kohler P, Kahlert CR. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis. 2020; ciab532. https://​doi.​org/​10.​1093/​cid/​ciab532
19.
Zurück zum Zitat Shiva S, Zahra P, Asghar A, Akbar PA, Azam S, Maryam F, et al. Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings. Iran J Allergy Asthma Immunol. 2008;7(3):157–62. Shiva S, Zahra P, Asghar A, Akbar PA, Azam S, Maryam F, et al. Selective immunoglobulin A deficiency in Iranian blood donors: prevalence, laboratory and clinical findings. Iran J Allergy Asthma Immunol. 2008;7(3):157–62.
20.
Zurück zum Zitat Pereira LF, Sapiña AM, Arroyo J, Viñuelas J, Bardaji RM, Prieto L. Prevalence of selective IgA deficiency in Spain: more than we thought. Blood. 1997;90(2):893.CrossRef Pereira LF, Sapiña AM, Arroyo J, Viñuelas J, Bardaji RM, Prieto L. Prevalence of selective IgA deficiency in Spain: more than we thought. Blood. 1997;90(2):893.CrossRef
21.
Zurück zum Zitat Kanoh T, Mizumoto T, Yasuda N, Koya M, Ohno Y, Uchino H, et al. Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis 1. Vox Sang. 1986;50(2):81–6.CrossRef Kanoh T, Mizumoto T, Yasuda N, Koya M, Ohno Y, Uchino H, et al. Selective IgA deficiency in Japanese blood donors: frequency and statistical analysis 1. Vox Sang. 1986;50(2):81–6.CrossRef
22.
Zurück zum Zitat Hanson L. Selective IgA deficiency. Primary and secondary immunodeficiency disorders. 1983:62–84. Hanson L. Selective IgA deficiency. Primary and secondary immunodeficiency disorders. 1983:62–84.
23.
Zurück zum Zitat Naito Y, Takagi T, Yamamoto T, Watanabe S. Association between selective IgA deficiency and COVID-19. J Clin Biochem Nutr. 2020;67(2):122–5.CrossRef Naito Y, Takagi T, Yamamoto T, Watanabe S. Association between selective IgA deficiency and COVID-19. J Clin Biochem Nutr. 2020;67(2):122–5.CrossRef
24.
Zurück zum Zitat Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233–8.CrossRef Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233–8.CrossRef
25.
Zurück zum Zitat Delavari S, Moeini Shad T, Rasouli S. Allergy in patients with selective IgA deficiency. Immunol Genet J. 2020;3(1):54–63. Delavari S, Moeini Shad T, Rasouli S. Allergy in patients with selective IgA deficiency. Immunol Genet J. 2020;3(1):54–63.
26.
Zurück zum Zitat Latiff AHA, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007;44(2):131–9.CrossRef Latiff AHA, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007;44(2):131–9.CrossRef
27.
Zurück zum Zitat Chao YX, Rötzschke O, Tan E-K. The role of IgA in COVID-19. Brain Behav Immun. 2020;87:182–3.CrossRef Chao YX, Rötzschke O, Tan E-K. The role of IgA in COVID-19. Brain Behav Immun. 2020;87:182–3.CrossRef
28.
Zurück zum Zitat Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis. 1991;163(1):1–6.CrossRef Onorato IM, Modlin JF, McBean AM, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis. 1991;163(1):1–6.CrossRef
29.
Zurück zum Zitat Ogra PL, Karzon DT, Righthand F, MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med. 1968;279(17):893–900.CrossRef Ogra PL, Karzon DT, Righthand F, MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med. 1968;279(17):893–900.CrossRef
Metadaten
Titel
Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group
verfasst von
Maral Barzegar-Amini
Mahmoud Mahmoudi
Maliheh Dadgarmoghaddam
Faramarz Farzad
Ali Qaraee Najafabadi
Farahzad Jabbari-Azad
Publikationsdatum
25.10.2021
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2022
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01149-6

Weitere Artikel der Ausgabe 1/2022

Journal of Clinical Immunology 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.